| Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes N Szentandrássy, K Kistamás, B Hegyi, B Horváth, F Ruzsnavszky, ... Pflügers Archiv-European Journal of Physiology 467, 1431-1443, 2015 | 62 | 2015 |
| Sarcolemmal Ca2+-entry through L-type Ca2+ channels controls the profile of Ca2+-activated Cl− current in canine ventricular myocytes B Horváth, K Váczi, B Hegyi, M Gönczi, B Dienes, K Kistamás, T Bányász, ... Journal of molecular and cellular cardiology 97, 125-139, 2016 | 32 | 2016 |
| Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes K Kistamas, N Szentandrassy, B Hegyi, K Vaczi, F Ruzsnavszky, ... J. Physiol. Pharmacol 66 (1), 73-81, 2015 | 30 | 2015 |
| Efficacy of selective NCX inhibition by ORM-10103 during simulated ischemia/reperfusion A Kormos, N Nagy, K Acsai, K Váczi, S Ágoston, P Pollesello, J Levijoki, ... European journal of pharmacology 740, 539-551, 2014 | 30 | 2014 |
| Ca2+-activated Cl− current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization B Hegyi, B Horváth, K Váczi, M Gönczi, K Kistamás, F Ruzsnavszky, ... Journal of molecular and cellular cardiology 109, 27-37, 2017 | 26 | 2017 |
| Dose-dependent electrophysiological effects of the myosin activator omecamtiv mecarbil in canine ventricular cardiomyocytes N Szentandrassy, B Horvath, K Vaczi, K Kistamas, L Masuda, J Magyar, ... J Physiol Pharmacol 67 (4), 483-489, 2016 | 26 | 2016 |
| Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes F Ruzsnavszky, B Hegyi, K Kistamás, K Váczi, B Horváth, ... Naunyn-Schmiedeberg's archives of pharmacology 387, 457-467, 2014 | 25 | 2014 |
| Action potential contour contributes to species differences in repolarization response to β-adrenergic stimulation L Sala, B Hegyi, C Bartolucci, C Altomare, M Rocchetti, K Váczi, ... EP Europace 20 (9), 1543-1552, 2018 | 22 | 2018 |
| The myosin activator omecamtiv mecarbil: a promising new inotropic agent P Nánási Jr, K Váczi, Z Papp Canadian Journal of Physiology and Pharmacology 94 (10), 1033-1039, 2016 | 17 | 2016 |
| Cytosolic calcium changes affect the incidence of early afterdepolarizations in canine ventricular myocytes B Horváth, B Hegyi, K Kistamás, K Váczi, T Bányász, J Magyar, ... Canadian Journal of Physiology and Pharmacology 93 (7), 527-534, 2015 | 16 | 2015 |
| Tetrodotoxin Blockade on Canine Cardiac L-Type Ca2+ Channels Depends on pH and Redox Potential B Hegyi, I Komáromi, K Kistamás, F Ruzsnavszky, K Váczi, B Horváth, ... Marine Drugs 11 (6), 2140-2153, 2013 | 15 | 2013 |
| Concept of relative variability of cardiac action potential duration and its test under various experimental conditions. J Magyar, K Kistamás, K Váczi, B Hegyi, B Horváth, T Bányász, PP Nánási, ... General Physiology and Biophysics 35 (1), 55-62, 2015 | 11 | 2015 |
| 9–Anthracene carboxylic acid is more suitable than DIDS for characterization of calcium-activated chloride current during canine ventricular action potential K Váczi, B Hegyi, F Ruzsnavszky, K Kistamás, B Horváth, T Bányász, ... Naunyn-Schmiedeberg's archives of pharmacology 388, 87-100, 2015 | 9 | 2015 |
| Effects of pioglitazone on cardiac ion currents and action potential morphology in canine ventricular myocytes K Kistamás, N Szentandrássy, B Hegyi, F Ruzsnavszky, K Váczi, ... European journal of pharmacology 710 (1-3), 10-19, 2013 | 8 | 2013 |
| Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells L Szabó, N Szentandrássy, K Kistamás, B Hegyi, F Ruzsnavszky, K Váczi, ... Naunyn-Schmiedeberg's archives of pharmacology 386, 239-246, 2013 | 8 | 2013 |
| Oxidative shift in tissue redox potential increases beat-to-beat variability of action potential duration K Kistamás, B Hegyi, K Váczi, B Horváth, T Bányász, J Magyar, ... Canadian Journal of Physiology and Pharmacology 93 (7), 563-568, 2015 | 6 | 2015 |
| Calcium activated chloride current in mammalian ventricular myocytes J Magyar, B Horváth, K Váczi, B Hegyi, M Gönczi, B Dienes, K Kistamás, ... Biophysical Journal 112 (3), 36a, 2017 | 1 | 2017 |
| Recent advances in research of cardiac calcium-activated chloride channels N Szentandrássy, B Hegyi, B Horváth, K Váczi, M Gönczi, B Dienes, ... | | 2017 |
| TMEM16A mediated calcium-activated chloride current synchronizes repolarization within mammalian ventricular myocardium B Hegyi, K Vaczi, M Gonczi, K Kistamas, F Ruzsnavszky, B Horvath, ... EUROPEAN HEART JOURNAL 35, 448-448, 2014 | | 2014 |
| The short term beat-to-beat variability of action potential duration depends on the the length of action potential and intracellular calcium K Vaczi, B Hegyi, F Ruzsnavszky, K Kistamas, B Horvath, ... ACTA PHYSIOLOGICA 211, 80-80, 2014 | | 2014 |
